All companies
Visit website
Milo Health
OperatingMilo Health, Inc.
Healthcare · Founded 2017
Better, simpler prescription care
Post-money valuation ⓘ
$13.8M
As of Dec 2022 · from Milo Health Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$98,686
Across 1 round since 2022
Latest share price
$10.00
Milo Health Common Stock 1 offering price
Financials
FY2020–FY2024 · from SEC filings · hover any figure for its source$0
−$439K
2020
$0
−$573K
2021
$4K
−$540K
2022
$10.4M
$2.6M
2023
$1.4M
$977K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$0
$4,343
$10,418,877
$1,438,291
Cost of goods sold
$0
$0
$233
$4,438,047
$0
Gross margin
—
—
95%
57%
100%
Net income
-$439,088
-$572,813
-$540,311
$2,586,747
$976,962
Taxes paid
$450
$0
$0
$335,569
$217,830
Balance sheet
Cash
$26,200
$58,001
$24,434
$2,360,286
$240,350
Accounts receivable
$0
$0
$4,343
$10,118,877
$1,438,291
Total assets
$26,200
$58,002
$24,434
$2,394,938
$3,136,464
Short-term debt
$0
$0
$734,456
$0
$0
Long-term debt
$129,077
$679,581
$0
$0
$0
Total liabilities
$129,077
$679,581
$734,456
$0
$0
Other
Headcount
—
2
2
2
2
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$13.8M
post-money
Milo Health Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $98.7K / $1MInvestors 25Post-money $13.8M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 3 of 4 annual reports (FY2022–FY2025)
25 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGARSource: ManualCIK 0001717109Share price $10.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.